SHBG (Extended): How to Interpret Your Result

Medical lab testing image for SHBG (Extended): How to Interpret Your Result

At a glance

  • SHBG normal range / 10 to 57 nmol/L in adult males, 18 to 144 nmol/L in adult females (assay-dependent)
  • Primary binding target / approximately 65 to 80 percent of circulating testosterone is bound to SHBG
  • Albumin-bound fraction / roughly 20 to 40 percent of testosterone binds loosely to albumin
  • Free testosterone / only 1 to 3 percent of total testosterone circulates unbound
  • High SHBG effect / lowers free testosterone even when total testosterone looks normal
  • Low SHBG effect / raises free testosterone and may amplify androgenic symptoms
  • Key modifiers / insulin resistance, obesity, liver disease, thyroid status, and exogenous hormones
  • Why "extended" matters / adds calculated free T and bioavailable T to the raw SHBG number
  • Fasting requirement / not strictly required, but morning draw before 10 AM improves consistency

What SHBG Actually Does

SHBG is a glycoprotein synthesized primarily in the liver. It acts as a transport shuttle and buffer for sex steroids in the bloodstream. Each SHBG molecule has a single high-affinity binding site that preferentially grabs dihydrotestosterone (DHT), then testosterone, then estradiol, in that order of affinity [1]. The protein's concentration directly determines how much hormone remains "free" (unbound) and able to enter cells and activate receptors.

Think of SHBG as a thermostat. When SHBG rises, less free hormone reaches target tissues. When it drops, more hormone becomes available. A 2016 review in the Journal of Clinical Endocrinology & Metabolism confirmed that SHBG concentrations account for the majority of inter-individual variation in free testosterone levels among men with similar total testosterone values [2]. Two men can share a total testosterone of 500 ng/dL yet have wildly different symptom profiles if one carries an SHBG of 20 nmol/L and the other sits at 60 nmol/L.

The "extended" designation on a lab panel means the laboratory calculates free testosterone and bioavailable testosterone (free plus albumin-bound) from the measured SHBG, total testosterone, and albumin. The Endocrine Society's 2018 guideline on testosterone deficiency explicitly recommends measuring or calculating free testosterone when SHBG is suspected to be abnormal [3]. Without that calculation, a clinician seeing a "normal" total testosterone could miss genuine androgen deficiency.

Normal SHBG Ranges and What Shifts Them

Reference intervals for SHBG vary by sex, age, and assay platform, but widely cited adult ranges are 10 to 57 nmol/L for males and 18 to 144 nmol/L for females [4]. Values trend upward with age in men at a rate of roughly 1 to 2 percent per year after age 40, according to longitudinal data from the European Male Aging Study (EMAS, N=3,369) [5].

Several physiologic and pathologic factors push SHBG in predictable directions:

Factors that raise SHBG: aging, hyperthyroidism, liver cirrhosis, estrogen therapy (oral contraceptives or oral menopausal HRT), anticonvulsants (phenytoin, carbamazepine), anorexia nervosa, and HIV infection [1][6].

Factors that lower SHBG: obesity and visceral adiposity, insulin resistance and type 2 diabetes, hypothyroidism, nephrotic syndrome, exogenous androgens (including TRT), high-dose glucocorticoids, and growth hormone excess (acromegaly) [1][7].

Insulin is one of the strongest suppressors. A cross-sectional analysis from the NHANES III cohort (N=1,408 men) found that each doubling of fasting insulin was associated with an 18.8 percent decrease in SHBG [7]. This relationship is why clinicians often see low SHBG clustering with metabolic syndrome.

Oral estrogen specifically raises SHBG through a hepatic first-pass effect. Transdermal estradiol bypasses the liver and has a much smaller impact, a distinction confirmed by a randomized crossover trial published in the Journal of Clinical Endocrinology & Metabolism (N=40 postmenopausal women) showing oral conjugated estrogens increased SHBG by 84 percent versus 12 percent with transdermal estradiol at comparable systemic estrogen levels [8].

How to Read the Extended Panel, Step by Step

An extended SHBG result typically contains four values. Here is a framework for interpreting them together:

Step 1. Check total testosterone. Is it within the lab's reference range? For adult males, the Endocrine Society defines the lower limit of normal as approximately 264 ng/dL (9.2 nmol/L) based on harmonized LC-MS/MS assays from the Framingham Heart Study and EMAS data [3].

Step 2. Look at SHBG. If SHBG is above or below the reference interval, the total testosterone number alone may be misleading. A total testosterone of 350 ng/dL with an SHBG of 55 nmol/L produces a very different free testosterone than the same total testosterone paired with an SHBG of 15 nmol/L.

Step 3. Evaluate calculated free testosterone. The Vermeulen equation, endorsed by the Endocrine Society, uses total testosterone, SHBG, and albumin to estimate free testosterone [9]. Adult male free testosterone below 5 to 9 ng/dL (laboratory-specific) suggests clinically meaningful androgen deficiency even if total testosterone appears normal. For adult females, free testosterone norms are much lower, typically 0.1 to 0.9 ng/dL, though female reference ranges remain less well standardized [10].

Step 4. Check bioavailable testosterone. This adds the albumin-bound fraction back in. Because albumin binds testosterone loosely, albumin-bound testosterone can dissociate at the capillary level and enter tissues. Bioavailable testosterone below the reference range reinforces a diagnosis of hypogonadism.

Step 5. Correlate with symptoms. Lab numbers alone do not make a diagnosis. The Endocrine Society guideline requires at least two morning testosterone measurements plus consistent signs and symptoms (low libido, erectile dysfunction, fatigue, reduced muscle mass, depressed mood) before initiating TRT [3].

High SHBG: Causes, Consequences, and Next Steps

When SHBG exceeds the upper reference limit, free testosterone drops disproportionately. A man with a total testosterone of 600 ng/dL and an SHBG of 80 nmol/L may have a free testosterone equivalent to someone with a total testosterone of 300 ng/dL and a normal SHBG. Symptoms of androgen deficiency can appear despite total testosterone that looks reassuring on paper.

Common clinical scenarios behind elevated SHBG include hyperthyroidism, chronic liver disease, prolonged caloric restriction, and use of oral estrogen-containing medications [6]. Aging itself is another driver. The EMAS data showed that SHBG increased by approximately 36 percent between ages 40 and 79 in community-dwelling European men, while total testosterone fell only modestly, meaning the decline in free testosterone was steeper than the decline in total testosterone [5].

A diagnostic workup for unexplained high SHBG should include thyroid function tests (TSH, free T4), liver function panel (AST, ALT, albumin), and a medication review. If a thyroid disorder or liver condition is identified and treated, SHBG often normalizes without direct intervention.

For men whose high SHBG is driving symptomatic hypogonadism and no reversible cause is found, the Endocrine Society guideline supports testosterone replacement, adjusting the target to free testosterone rather than total testosterone [3]. Injectable testosterone (cypionate or enanthate) tends to be more effective in this scenario than topical formulations, because higher peak levels can partially overcome the binding capacity of elevated SHBG.

Low SHBG: Causes, Consequences, and Next Steps

Low SHBG increases the proportion of free testosterone relative to total testosterone. In isolation, this might sound beneficial, but the clinical picture is more nuanced. Low SHBG is tightly linked to insulin resistance, and the metabolic environment that suppresses SHBG often impairs androgen receptor sensitivity simultaneously [7][11].

In women, low SHBG with elevated free testosterone can drive androgenic symptoms: acne, hirsutism, and androgenic alopecia. This combination is a hallmark of polycystic ovary syndrome (PCOS). The 2023 International Evidence-Based Guideline for the Assessment and Management of PCOS lists SHBG-adjusted free androgen index (FAI = total testosterone / SHBG x 100) as a recommended tool for biochemical hyperandrogenism assessment [12].

In men, low SHBG can inflate total testosterone, masking underlying metabolic dysfunction. A man with metabolic syndrome may present with a total testosterone of 450 ng/dL and an SHBG of 12 nmol/L. That low SHBG makes the total number look adequate, but it also signals significant insulin resistance. Addressing the metabolic root (weight loss, improved insulin sensitivity) tends to raise SHBG and produce better long-term hormonal balance than treating testosterone in isolation.

Interventions that raise SHBG in the context of metabolic disease mirror interventions that improve insulin sensitivity. Weight loss is the most consistent lever. A meta-analysis of 24 studies (N=1,462) published in Obesity Reviews found that a 10 percent reduction in body weight increased SHBG by a mean of 29.6 percent [13]. Metformin, often prescribed for type 2 diabetes, does not reliably raise SHBG, as its SHBG effect is inconsistent across trials [14].

SHBG and Estrogen: The Other Half of the Equation

Although SHBG binds testosterone with higher affinity, it also regulates estradiol availability. This matters in hormone replacement for both sexes. In men on TRT, rising estradiol levels can stimulate hepatic SHBG production, partially offsetting the androgenic benefit of testosterone replacement [1]. Monitoring SHBG alongside estradiol during TRT helps clinicians distinguish between genuine estrogen excess and an SHBG-mediated artifact.

In postmenopausal women on HRT, the route of estrogen administration has a dramatic effect on SHBG, as discussed above [8]. Oral estrogen sharply raises SHBG, which can bind and reduce bioavailable testosterone, sometimes worsening libido or energy. Transdermal estradiol avoids this hepatic first-pass SHBG spike. The North American Menopause Society (NAMS) 2022 position statement notes that transdermal estrogen is preferred in women with hypertriglyceridemia or thrombotic risk, and the SHBG-sparing effect is an additional clinical consideration [15].

For women with PCOS, oral contraceptives raise SHBG and reduce free androgen levels, which is one mechanism by which they improve acne and hirsutism. The ethinyl estradiol component drives SHBG upward, while the progestin component (particularly anti-androgenic progestins like cyproterone acetate or drospirenone) adds a direct androgen receptor blocking effect [12].

When to Retest and How Often

SHBG is not a value that changes overnight. Rechecking sooner than 6 to 8 weeks after an intervention (starting TRT, changing estrogen route, initiating weight loss) rarely provides useful data. For monitoring during stable TRT, the Endocrine Society recommends checking total testosterone, free testosterone, and SHBG at 3, 6, and 12 months, then annually if stable [3].

Morning blood draws (before 10 AM) reduce variability, because SHBG has a mild diurnal pattern and testosterone peaks in the early morning [3]. Fasting is not strictly required for SHBG, but concurrent glucose and insulin measurements (which inform SHBG interpretation) do require fasting. Drawing the full panel fasting and early simplifies things.

A common pitfall is chasing SHBG as an isolated number. SHBG is a context marker. It tells you about hepatic estrogen exposure, insulin status, thyroid function, and nutritional state. Treating the SHBG value without investigating its cause is like treating a fever without looking for infection.

Dr. Shalender Bhasin, principal investigator of the Testosterone Trials (TTrials), has stated: "Free testosterone, calculated using equilibrium dialysis or the Vermeulen equation, provides a more accurate assessment of androgen status than total testosterone in men with borderline values or conditions that alter SHBG" [3].

The American Association of Clinical Endocrinologists (AACE) 2020 updated guidelines for hypogonadism evaluation echo this position, recommending calculated free testosterone whenever SHBG is known or suspected to be abnormal, particularly in obese patients and those over age 65 [16].

Supplements and Lifestyle Claims Around SHBG

A quick internet search for "how to lower SHBG" returns dozens of supplement recommendations. The evidence behind most of them is thin. Boron supplementation (6 to 10 mg/day) has shown modest SHBG reductions in a small pilot study (N=8), but the trial was too small and short to draw clinical conclusions [17]. Magnesium status correlates with SHBG in observational data, but no randomized trial has demonstrated that magnesium supplementation meaningfully lowers SHBG in replete individuals [18].

Resistance training has a more credible evidence base. A 12-week resistance training program in middle-aged men (N=20) reduced SHBG by 16 percent and increased free testosterone by 8.5 percent, per a study in the European Journal of Applied Physiology [19]. The effect likely operates through improved insulin sensitivity and reduced visceral fat rather than a direct hepatic mechanism.

Dietary patterns matter, too. Very-low-calorie diets and prolonged fasting raise SHBG, while diets higher in protein and moderate in carbohydrate tend to keep SHBG lower [1]. Extreme carbohydrate restriction (ketogenic diets) has mixed data, with some studies showing SHBG increases from weight loss that offset any macronutrient-mediated SHBG suppression.

The safest clinical advice: address underlying metabolic health first. If SHBG is high from hyperthyroidism, treat the thyroid. If SHBG is low from obesity, pursue structured weight loss. Supplements are not a substitute for diagnosis.

Frequently asked questions

What is a normal SHBG level?
For adult males, the typical reference range is 10 to 57 nmol/L. For adult females, it is 18 to 144 nmol/L. Ranges vary by assay and laboratory, so always interpret your result against the reference interval printed on your specific lab report.
What does a high SHBG level mean?
High SHBG means more testosterone and estradiol are bound and unavailable to tissues. Common causes include aging, hyperthyroidism, liver disease, oral estrogen use, and low caloric intake. Symptoms of androgen deficiency can appear even when total testosterone is within range.
What does a low SHBG level mean?
Low SHBG increases the fraction of free testosterone. It is strongly associated with insulin resistance, obesity, type 2 diabetes, hypothyroidism, and exogenous androgen use. In women, low SHBG with elevated free testosterone may indicate PCOS.
Why is the test called SHBG extended?
The extended panel measures SHBG concentration and then calculates free testosterone and bioavailable testosterone using the Vermeulen equation. This gives a more complete picture of androgen status than SHBG or total testosterone alone.
Can I lower my SHBG naturally?
Weight loss, resistance exercise, and improved insulin sensitivity are the most evidence-supported approaches for raising or lowering SHBG toward normal. Supplements like boron have very limited evidence. The priority should be identifying and treating the underlying cause of the abnormal SHBG.
Does SHBG affect estrogen levels?
Yes. SHBG binds estradiol as well as testosterone, though with lower affinity. Higher SHBG reduces free estradiol availability. Oral estrogen raises SHBG through a liver first-pass effect, while transdermal estrogen has minimal impact on SHBG.
Should I fast before an SHBG blood test?
Fasting is not strictly required for SHBG itself. However, concurrent insulin, glucose, and lipid measurements do require fasting, and testosterone is best drawn before 10 AM. A morning fasting draw covers all of these optimally.
How often should SHBG be rechecked?
During TRT or HRT, the Endocrine Society recommends checking at 3, 6, and 12 months, then annually if stable. After a new intervention like weight loss or thyroid treatment, allow at least 6 to 8 weeks before rechecking.
Can TRT change my SHBG?
Yes. Exogenous testosterone typically suppresses SHBG, particularly injectable formulations. This is one reason why free testosterone may rise more than total testosterone during TRT. Clinicians adjust monitoring accordingly.
Is SHBG relevant for women on HRT?
Absolutely. Oral estrogen raises SHBG significantly, which can lower bioavailable testosterone and potentially affect libido and energy. Transdermal estrogen bypasses the liver and has a much smaller effect on SHBG, making it preferred in some clinical scenarios.
What is the free androgen index and how does it relate to SHBG?
The free androgen index (FAI) is calculated as total testosterone divided by SHBG, multiplied by 100. It is commonly used in women to screen for biochemical hyperandrogenism in PCOS. A high FAI suggests excess free androgen activity.
Does metformin affect SHBG?
Metformin's effect on SHBG is inconsistent across clinical trials. While it improves insulin sensitivity, it does not reliably raise SHBG. Weight loss and exercise are more dependable strategies for normalizing SHBG in insulin-resistant patients.

References

  1. Hammond GL. Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. J Endocrinol. 2016;230(1):R13-R25. https://pubmed.ncbi.nlm.nih.gov/27113851
  2. Goldman AL, Bhasin S, Wu FCW, et al. A reappraisal of testosterone's binding in circulation: physiological and clinical implications. Endocr Rev. 2017;38(4):302-324. https://pubmed.ncbi.nlm.nih.gov/28673039
  3. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364
  4. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012
  5. Tajar A, Forti G, O'Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95(4):1810-1818. https://pubmed.ncbi.nlm.nih.gov/20173018
  6. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(Pt 6):532-541. https://pubmed.ncbi.nlm.nih.gov/2080856
  7. Pugeat M, Crave JC, Elmidani M, et al. Pathophysiology of sex hormone binding globulin (SHBG): relation to insulin. J Steroid Biochem Mol Biol. 1991;40(4-6):841-849. https://pubmed.ncbi.nlm.nih.gov/1958583
  8. Vongpatanasin W, Tuncel M, Wang Z, et al. Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol. 2003;41(8):1358-1363. https://pubmed.ncbi.nlm.nih.gov/12706932
  9. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012
  10. Rosner W, Auchus RJ, Azziz R, et al. Position statement: utility, limitations, and pitfalls in measuring testosterone. J Clin Endocrinol Metab. 2007;92(2):405-413. https://pubmed.ncbi.nlm.nih.gov/17090633
  11. Wallace IR, McKinley MC, Bell PM, Hunter SJ. Sex hormone binding globulin and insulin resistance. Clin Endocrinol (Oxf). 2013;78(3):321-329. https://pubmed.ncbi.nlm.nih.gov/23121642
  12. Teede HJ, Misso ML, Costello MF, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. J Clin Endocrinol Metab. 2023;108(10):2447-2469. https://pubmed.ncbi.nlm.nih.gov/37580314
  13. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168(6):829-843. https://pubmed.ncbi.nlm.nih.gov/23482592
  14. Morgante G, Tosti C, Orvieto R, et al. Metformin improves semen characteristics of oligo-terato-asthenozoospermic men with metabolic syndrome. Fertil Steril. 2011;95(6):2150-2152. https://pubmed.ncbi.nlm.nih.gov/21071026
  15. The 2022 hormone therapy position statement of the North American Menopause Society. Menopause. 2022;29(7):767-794. https://pubmed.ncbi.nlm.nih.gov/35797481
  16. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923
  17. Naghii MR, Mofid M, Asgari AR, et al. Comparative effects of daily and weekly boron supplementation on plasma steroid hormones and proinflammatory cytokines. J Trace Elem Med Biol. 2011;25(1):54-58. https://pubmed.ncbi.nlm.nih.gov/21129941
  18. Maggio M, Ceda GP, Lauretani F, et al. Magnesium and anabolic hormones in older men. Int J Androl. 2011;34(6 Pt 2):e594-e600. https://pubmed.ncbi.nlm.nih.gov/21675994
  19. Kraemer WJ, Ratamess NA. Hormonal responses and adaptations to resistance exercise and training. Sports Med. 2005;35(4):339-361. https://pubmed.ncbi.nlm.nih.gov/15831061